Prescription and Over-the-Counter Drug Product List 41ST EDITION Cumulative Supplement Number 06 : June 2021 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ABIRATERONE ACETATE TABLET;ORAL ABIRATERONE ACETATE >A> AB QILU 500MG A 212462 002 Jun 25, 2021 Jun NEWA

ACETAMINOPHEN; BUTALBITAL TABLET;ORAL BUTALBITAL AND ACETAMINOPHEN >A> AA ALVOGEN 300MG;50MG A 207635 001 Jun 05, 2017 Jun CAHN >A> AA 325MG;50MG A 205120 001 Oct 30, 2015 Jun CAHN >D> AA CNTY LINE PHARMS 300MG;50MG A 207635 001 Jun 05, 2017 Jun CAHN >D> AA 325MG;50MG A 205120 001 Oct 30, 2015 Jun CAHN

ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA ALVOGEN 325MG;50MG;40MG A 204984 001 Jan 10, 2017 Jun CAHN >D> AA CNTY LINE PHARMS 325MG;50MG;40MG A 204984 001 Jan 10, 2017 Jun CAHN

ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >D> AB ! HERITAGE PHARMS INC 500MG A 090779 001 Jul 14, 2011 Jun CAHN >A> AB ! INDICUS PHARMA 500MG A 090779 001 Jul 14, 2011 Jun CAHN

ACLIDINIUM BROMIDE; FUMARATE POWDER, METERED;INHALATION DUAKLIR PRESSAIR >D> ASTRAZENECA 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Jun CHRS >A> +! 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Jun CHRS

ACYCLOVIR OINTMENT;TOPICAL ACYCLOVIR >D> AB ANDA REPOSITORY 5% A 206437 001 Jul 31, 2017 Jun DISC >A> @ 5% A 206437 001 Jul 31, 2017 Jun DISC

ACYCLOVIR SODIUM INJECTABLE;INJECTION ACYCLOVIR SODIUM >D> AP EXELA PHARMA EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun CAHN >A> AP NAMIGEN LLC EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun CAHN

ALENDRONATE SODIUM TABLET;ORAL ALENDRONATE SODIUM >D> AB JUBILANT CADISTA EQ 5MG BASE A 090557 001 Feb 18, 2010 Jun DISC >A> @ EQ 5MG BASE A 090557 001 Feb 18, 2010 Jun DISC >D> AB EQ 10MG BASE A 090557 002 Feb 18, 2010 Jun DISC >A> @ EQ 10MG BASE A 090557 002 Feb 18, 2010 Jun DISC >D> AB EQ 35MG BASE A 090557 003 Feb 18, 2010 Jun DISC >A> @ EQ 35MG BASE A 090557 003 Feb 18, 2010 Jun DISC >D> AB EQ 70MG BASE A 090557 004 Feb 18, 2010 Jun DISC >A> @ EQ 70MG BASE A 090557 004 Feb 18, 2010 Jun DISC

ALENDRONATE SODIUM; CHOLECALCIFEROL TABLET;ORAL FOSAMAX PLUS D >D> + MERCK EQ 70MG BASE;2,800 IU N 021762 001 Apr 07, 2005 Jun CAHN >D> +! EQ 70MG BASE;5,600 IU N 021762 002 Apr 26, 2007 Jun CAHN >A> + ORGANON EQ 70MG BASE;2,800 IU N 021762 001 Apr 07, 2005 Jun CAHN >A> +! EQ 70MG BASE;5,600 IU N 021762 002 Apr 26, 2007 Jun CAHN

Page 1 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ALLOPURINOL TABLET;ORAL ALLOPURINOL >D> AB APOTEX INC 100MG A 077353 001 Sep 08, 2005 Jun CAHN >D> AB 300MG A 077353 002 Sep 08, 2005 Jun CAHN >A> AB CHARTWELL 100MG A 077353 001 Sep 08, 2005 Jun CAHN >A> AB 300MG A 077353 002 Sep 08, 2005 Jun CAHN

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >D> AB MYLAN 0.25MG A 074215 001 Jan 27, 1994 Jun DISC >A> @ 0.25MG A 074215 001 Jan 27, 1994 Jun DISC >D> AB 0.5MG A 074215 002 Jan 27, 1994 Jun DISC >A> @ 0.5MG A 074215 002 Jan 27, 1994 Jun DISC >D> AB 1MG A 074215 003 Jan 27, 1994 Jun DISC >A> @ 1MG A 074215 003 Jan 27, 1994 Jun DISC >D> AB 2MG A 074215 004 Jan 27, 1994 Jun DISC >A> @ 2MG A 074215 004 Jan 27, 1994 Jun DISC

AMINOCAPROIC ACID TABLET;ORAL AMINOCAPROIC ACID >A> AB EDENBRIDGE PHARMS 500MG A 212110 001 Jun 14, 2021 Jun NEWA

AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >D> AB MYLAN 10MG A 086009 002 Apr 26, 1978 Jun DISC >A> @ 10MG A 086009 002 Apr 26, 1978 Jun DISC >D> AB 25MG A 086009 003 Apr 10, 1978 Jun DISC >A> @ 25MG A 086009 003 Apr 10, 1978 Jun DISC >D> AB 50MG A 086009 001 Apr 10, 1978 Jun DISC >A> @ 50MG A 086009 001 Apr 10, 1978 Jun DISC >D> AB 75MG A 086009 004 Apr 10, 1978 Jun DISC >A> @ 75MG A 086009 004 Apr 10, 1978 Jun DISC >D> AB 100MG A 086009 005 Apr 26, 1978 Jun DISC >A> @ 100MG A 086009 005 Apr 26, 1978 Jun DISC >D> AB 150MG A 086009 006 Apr 26, 1978 Jun DISC >A> @ 150MG A 086009 006 Apr 26, 1978 Jun DISC

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL TABLET;ORAL AMLODIPINE AND OLMESARTAN MEDOXOMIL >D> AB JUBILANT GENERICS EQ 5MG BASE;20MG A 207450 001 May 15, 2017 Jun DISC >A> @ EQ 5MG BASE;20MG A 207450 001 May 15, 2017 Jun DISC >D> AB EQ 5MG BASE;40MG A 207450 002 May 15, 2017 Jun DISC >A> @ EQ 5MG BASE;40MG A 207450 002 May 15, 2017 Jun DISC >D> AB EQ 10MG BASE;20MG A 207450 003 May 15, 2017 Jun DISC >A> @ EQ 10MG BASE;20MG A 207450 003 May 15, 2017 Jun DISC >D> AB EQ 10MG BASE;40MG A 207450 004 May 15, 2017 Jun DISC >A> @ EQ 10MG BASE;40MG A 207450 004 May 15, 2017 Jun DISC

AMOXICILLIN CAPSULE;ORAL AMOXICILLIN >D> AB BELCHER PHARMS 250MG A 062058 001 Aug 03, 1978 Jun CAHN >D> AB 500MG A 062058 002 Aug 03, 1978 Jun CAHN >A> AB CHARTWELL 250MG A 062058 001 Aug 03, 1978 Jun CAHN >A> AB 500MG A 062058 002 Aug 03, 1978 Jun CAHN

AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE >D> AA GLENMARK PHARMS LTD 5MG A 212186 001 Jan 27, 2021 Jun DISC >A> @ 5MG A 212186 001 Jan 27, 2021 Jun DISC >D> AA 10MG A 212186 002 Jan 27, 2021 Jun DISC >A> @ 10MG A 212186 002 Jan 27, 2021 Jun DISC

Page 2 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

APREMILAST TABLET;ORAL APREMILAST >A> AB AMNEAL 10MG A 211782 001 Jun 30, 2021 Jun NEWA >A> AB 20MG A 211782 002 Jun 30, 2021 Jun NEWA >A> AB 30MG A 211782 003 Jun 30, 2021 Jun NEWA

ARFORMOTEROL TARTRATE SOLUTION;INHALATION >A> TARTRATE >A> AN AXAR PHARMS INC EQ 0.015MG BASE/2ML A 213762 001 Jun 22, 2021 Jun NFTG >A> AN CIPLA EQ 0.015MG BASE/2ML A 207306 001 Jun 22, 2021 Jun NFTG >A> AN GLENMARK PHARMS LTD EQ 0.015MG BASE/2ML A 213132 001 Jun 22, 2021 Jun NFTG

ARGATROBAN SOLUTION;INTRAVENOUS ARGATROBAN IN SODIUM CHLORIDE >A> +! ACCORD HLTHCARE 50MG/50ML (1MG/ML) N 212035 001 Jun 07, 2021 Jun NEWA

AVAPRITINIB TABLET;ORAL AYVAKIT >A> + BLUEPRINT MEDICINES 25MG N 212608 004 Jun 16, 2021 Jun NEWA >A> + 50MG N 212608 005 Jun 16, 2021 Jun NEWA

BACITRACIN >D> INJECTABLE;INJECTION >D> BACITRACIN >D> ! XELLIA PHARMS APS 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Jun DISC >A> @ 50,000 UNITS/VIAL A 203177 001 Aug 25, 2014 Jun DISC

BACLOFEN TABLET;ORAL BACLOFEN >A> AB IMPAX 5MG A 077971 003 Jul 07, 2021 Jun NEWA >A> AB 10MG A 077971 001 Oct 26, 2007 Jun CAHN >A> AB 20MG A 077971 002 Oct 26, 2007 Jun CAHN >D> AB IMPAX LABS 10MG A 077971 001 Oct 26, 2007 Jun CAHN >D> AB 20MG A 077971 002 Oct 26, 2007 Jun CAHN

>A> BRINCIDOFOVIR >A> SUSPENSION;ORAL >A> TEMBEXA >A> +! CHIMERIX 10MG/ML N 214460 001 Jun 04, 2021 Jun NEWA >A> TABLET;ORAL >A> TEMBEXA >A> +! CHIMERIX 100MG N 214461 001 Jun 04, 2021 Jun NEWA

>A> BUPIVACAINE; MELOXICAM >A> SOLUTION, EXTENDED RELEASE;PERIARTICULAR >A> ZYNRELEF KIT >A> +! HERON THERAPS INC 60MG/2.3ML N 211988 001 May 12, 2021 Jun NEWA (29.25MG/ML);1.8MG/2.3ML >A> +! 200MG/7ML (29.25MG/ML);6MG/7ML N 211988 002 May 12, 2021 Jun NEWA (0.88MG/ML) >A> +! 300MG/10.5ML N 211988 003 May 12, 2021 Jun NEWA (29.25MG/ML);9MG/10.5ML >A> +! 400MG/14ML N 211988 004 May 12, 2021 Jun NEWA (29.25MG/ML);12MG/14ML

BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL BUPRENORPHINE >A> AB WATSON LABS TEVA 7.5MCG/HR A 204937 005 Jun 29, 2021 Jun NEWA

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE TABLET;SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE >A> AB ALKEM LABS LTD EQ 2MG BASE;EQ 0.5MG BASE A 214930 001 Jun 15, 2021 Jun NEWA >A> AB EQ 8MG BASE;EQ 2MG BASE A 214930 002 Jun 15, 2021 Jun NEWA

Page 3 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CALCIUM ACETATE TABLET;ORAL CALCIUM ACETATE >D> AB ! PADDOCK LLC 667MG A 091561 001 Apr 13, 2011 Jun CHRS >A> AB 667MG A 091561 001 Apr 13, 2011 Jun CHRS

CALCIUM GLUCONATE SOLUTION;INTRAVENOUS CALCIUM GLUCONATE IN SODIUM CHLORIDE >A> +! HQ SPCLT PHARMA 1GM/100ML (10MG/ML) N 210906 003 Jun 04, 2021 Jun NEWA

>D> CAPREOMYCIN SULFATE >D> INJECTABLE;INJECTION >D> CAPASTAT SULFATE >D> +! AKORN EQ 1GM BASE/VIAL N 050095 001 Jun 02, 1971 Jun DISC >A> + @ EQ 1GM BASE/VIAL N 050095 001 Jun 02, 1971 Jun DISC

CARFILZOMIB POWDER;INTRAVENOUS >A> CARFILZOMIB >A> AP BRECKENRIDGE 10MG/VIAL A 209330 001 Jun 11, 2021 Jun NFTG >A> AP 60MG/VIAL A 209330 002 Jun 11, 2021 Jun NEWA

CELECOXIB CAPSULE;ORAL CELECOXIB >D> AB ACIC PHARMS 200MG A 212925 001 Dec 09, 2020 Jun DISC >A> @ 200MG A 212925 001 Dec 09, 2020 Jun DISC >D> AB 400MG A 212925 002 Dec 09, 2020 Jun DISC >A> @ 400MG A 212925 002 Dec 09, 2020 Jun DISC >D> AB JUBILANT GENERICS 50MG A 207061 001 Apr 04, 2017 Jun DISC >A> @ 50MG A 207061 001 Apr 04, 2017 Jun DISC >D> AB 100MG A 207061 002 Apr 04, 2017 Jun DISC >A> @ 100MG A 207061 002 Apr 04, 2017 Jun DISC >D> AB 200MG A 207061 003 Apr 04, 2017 Jun DISC >A> @ 200MG A 207061 003 Apr 04, 2017 Jun DISC >D> AB 400MG A 207061 004 Apr 04, 2017 Jun DISC >A> @ 400MG A 207061 004 Apr 04, 2017 Jun DISC >D> @ YILING 50MG A 211412 001 Mar 06, 2020 Jun CMFD >A> AB 50MG A 211412 001 Mar 06, 2020 Jun CMFD >D> @ 100MG A 211412 002 Mar 06, 2020 Jun CMFD >A> AB 100MG A 211412 002 Mar 06, 2020 Jun CMFD >D> @ 200MG A 211412 003 Mar 06, 2020 Jun CMFD >A> AB 200MG A 211412 003 Mar 06, 2020 Jun CMFD >D> @ 400MG A 211412 004 Mar 06, 2020 Jun CMFD >A> AB 400MG A 211412 004 Mar 06, 2020 Jun CMFD

CHOLINE FENOFIBRATE CAPSULE, DELAYED RELEASE;ORAL FENOFIBRIC ACID >D> AB YICHANG HUMANWELL EQ 45MG FENOFIBRIC ACID A 212562 001 Dec 23, 2020 Jun DISC >A> @ EQ 45MG FENOFIBRIC ACID A 212562 001 Dec 23, 2020 Jun DISC >D> AB EQ 135MG FENOFIBRIC ACID A 212562 002 Dec 23, 2020 Jun DISC >A> @ EQ 135MG FENOFIBRIC ACID A 212562 002 Dec 23, 2020 Jun DISC

CICLOPIROX GEL;TOPICAL CICLOPIROX >A> AB +! ALVOGEN 0.77% N 020519 001 Jul 21, 1997 Jun CAHN >D> AB +! CNTY LINE PHARMS 0.77% N 020519 001 Jul 21, 1997 Jun CAHN

CIPROFLOXACIN INJECTABLE, SUSPENSION;OTIC OTIPRIO >A> +! ALK ABELLO 6% (60MG/ML) N 207986 001 Dec 10, 2015 Jun CAHN >D> +! OTONOMY INC 6% (60MG/ML) N 207986 001 Dec 10, 2015 Jun CAHN

Page 4 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CLINDAMYCIN PHOSPHATE LOTION;TOPICAL CLINDAMYCIN PHOSPHATE >A> AB TARO PHARMS EQ 1% BASE A 214526 001 Jun 28, 2021 Jun NEWA

CLOBAZAM TABLET;ORAL CLOBAZAM >D> AB CELLTRION 10MG A 211959 001 Dec 09, 2020 Jun DISC >A> @ 10MG A 211959 001 Dec 09, 2020 Jun DISC >D> AB 20MG A 211959 002 Dec 09, 2020 Jun DISC >A> @ 20MG A 211959 002 Dec 09, 2020 Jun DISC

CLOBETASOL PROPIONATE SHAMPOO;TOPICAL CLOBETASOL PROPIONATE >A> AB AMNEAL 0.05% A 214895 001 Jun 14, 2021 Jun NEWA

CYCLOSPORINE EMULSION;OPHTHALMIC VERKAZIA >A> +! SANTEN 0.1% N 214965 001 Jun 23, 2021 Jun NEWA

DABIGATRAN ETEXILATE MESYLATE >A> PELLET;ORAL >A> PRADAXA >A> + BOEHRINGER INGELHEIM EQ 20MG BASE/PACKET N 214358 001 Jun 21, 2021 Jun NEWA >A> + EQ 30MG BASE/PACKET N 214358 002 Jun 21, 2021 Jun NEWA >A> + EQ 40MG BASE/PACKET N 214358 003 Jun 21, 2021 Jun NEWA >A> + EQ 50MG BASE/PACKET N 214358 004 Jun 21, 2021 Jun NEWA >A> + EQ 110MG BASE/PACKET N 214358 005 Jun 21, 2021 Jun NEWA >A> +! EQ 150MG BASE/PACKET N 214358 006 Jun 21, 2021 Jun NEWA

DAPSONE TABLET;ORAL DAPSONE >D> AB ALVOGEN 25MG A 205429 001 Jan 07, 2016 Jun CAHN >A> AB 25MG A 205429 001 Jan 07, 2016 Jun CAHN >D> AB 100MG A 205429 002 Jan 07, 2016 Jun CAHN >A> AB 100MG A 205429 002 Jan 07, 2016 Jun CAHN

DAPTOMYCIN POWDER;INTRAVENOUS DAPTOMYCIN >A> AP HONG KONG 500MG/VIAL A 213623 001 Jun 29, 2021 Jun NEWA >A> +! HOSPIRA INC 350MG/VIAL N 210282 001 Jun 21, 2021 Jun NEWA >A> +! 500MG/VIAL N 210282 002 Jun 21, 2021 Jun NEWA POWDER;IV (INFUSION) DAPTOMYCIN >A> AP HONG KONG 350MG/VIAL A 213786 001 Jun 29, 2021 Jun NEWA

DARIFENACIN HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL HYDROBROMIDE >D> AB JUBILANT GENERICS EQ 7.5MG BASE A 205550 001 Oct 12, 2016 Jun DISC >A> @ EQ 7.5MG BASE A 205550 001 Oct 12, 2016 Jun DISC >D> AB EQ 15MG BASE A 205550 002 Oct 12, 2016 Jun DISC >A> @ EQ 15MG BASE A 205550 002 Oct 12, 2016 Jun DISC

DECITABINE INJECTABLE;INTRAVENOUS DECITABINE >A> AP HONG KONG 50MG/VIAL A 212959 001 Jul 02, 2021 Jun NEWA

DESIPRAMINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> AB ALEMBIC PHARMS LTD 10MG A 209785 001 Jul 07, 2021 Jun NEWA >A> AB 25MG A 209785 002 Jul 07, 2021 Jun NEWA >A> AB 50MG A 209785 003 Jul 07, 2021 Jun NEWA >A> AB 75MG A 209785 004 Jul 07, 2021 Jun NEWA

Page 5 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DESIPRAMINE HYDROCHLORIDE TABLET;ORAL DESIPRAMINE HYDROCHLORIDE >A> AB 100MG A 209785 005 Jul 07, 2021 Jun NEWA >A> AB 150MG A 209785 006 Jul 07, 2021 Jun NEWA

DESLORATADINE; PSEUDOEPHEDRINE SULFATE TABLET, EXTENDED RELEASE;ORAL CLARINEX-D 12 HOUR >D> +! MERCK SHARP DOHME 2.5MG;120MG N 021313 001 Feb 01, 2006 Jun CAHN >A> +! ORGANON 2.5MG;120MG N 021313 001 Feb 01, 2006 Jun CAHN

DEXAMETHASONE TABLET;ORAL DEXAMETHASONE >A> BP ALVOGEN 0.5MG A 088481 002 Apr 28, 1983 Jun CAHN >A> BP 0.75MG A 088481 003 Apr 28, 1983 Jun CAHN >A> BP 4MG A 088481 004 Apr 28, 1983 Jun CAHN >A> BP 6MG A 088481 001 Nov 28, 1983 Jun CAHN >D> BP FERA PHARMS LLC 0.5MG A 088481 002 Apr 28, 1983 Jun CAHN >D> BP 0.75MG A 088481 003 Apr 28, 1983 Jun CAHN >D> BP 4MG A 088481 004 Apr 28, 1983 Jun CAHN >D> BP 6MG A 088481 001 Nov 28, 1983 Jun CAHN

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION DEXMEDETOMIDINE HYDROCHLORIDE >D> @ HONG KONG EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Jun CMFD BASE/ML) >A> AP EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Jun CMFD BASE/ML)

DICYCLOMINE HYDROCHLORIDE INJECTABLE;INJECTION DICYCLOMINE HYDROCHLORIDE >A> AP PRAXGEN 10MG/ML A 212058 001 Apr 26, 2019 Jun CAHN >D> AP SUNGEN PHARMA 10MG/ML A 212058 001 Apr 26, 2019 Jun CAHN

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >A> AP EUGIA PHARMA 20MG/2ML (10MG/ML) A 214575 001 Jun 25, 2021 Jun NEWA >A> AP 80MG/8ML (10MG/ML) A 214575 002 Jun 25, 2021 Jun NEWA >A> AP 160MG/16ML (10MG/ML) A 214575 003 Jun 25, 2021 Jun NEWA >A> AP GLAND PHARMA LTD 20MG/2ML (10MG/ML) A 213510 001 Jul 01, 2021 Jun NEWA >A> AP 80MG/8ML (10MG/ML) A 213510 002 Jul 01, 2021 Jun NEWA >A> AP 160MG/16ML (10MG/ML) A 213510 003 Jul 01, 2021 Jun NEWA >D> @ HONG KONG 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Jun CMFD >A> AP 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Jun CMFD >D> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Jun CMFD >A> AP 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Jun CMFD >D> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Jun CMFD >A> AP 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Jun CMFD

DOXYCYCLINE CAPSULE;ORAL MONODOX >D> + @ CHARTWELL RX EQ 50MG BASE N 050641 002 Feb 10, 1992 Jun CMFD >A> AB + EQ 50MG BASE N 050641 002 Feb 10, 1992 Jun CMFD >D> + @ EQ 75MG BASE N 050641 003 Oct 18, 2006 Jun CMFD >A> AB + EQ 75MG BASE N 050641 003 Oct 18, 2006 Jun CMFD >D> + @ EQ 100MG BASE N 050641 001 Dec 29, 1989 Jun CMFD >A> AB + EQ 100MG BASE N 050641 001 Dec 29, 1989 Jun CMFD FOR SUSPENSION;ORAL DOXYCYCLINE >A> AB CHARTWELL EQ 25MG BASE/5ML A 065454 001 Jul 16, 2008 Jun CAHN >D> AB CHARTWELL LIFE SCI EQ 25MG BASE/5ML A 065454 001 Jul 16, 2008 Jun CAHN

Page 6 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOXYCYCLINE HYCLATE CAPSULE;ORAL DOXYCYCLINE HYCLATE >A> AB CHARTWELL EQ 50MG BASE A 062500 001 Sep 11, 1984 Jun CAHN >A> AB EQ 100MG BASE A 062500 002 Sep 11, 1984 Jun CAHN >D> AB CHARTWELL LIFE SCI EQ 50MG BASE A 062500 001 Sep 11, 1984 Jun CAHN >D> AB EQ 100MG BASE A 062500 002 Sep 11, 1984 Jun CAHN TABLET;ORAL DOXYCYCLINE HYCLATE >A> AB CHARTWELL EQ 100MG BASE A 062505 001 Sep 11, 1984 Jun CAHN >D> AB CHARTWELL LIFE SCI EQ 100MG BASE A 062505 001 Sep 11, 1984 Jun CAHN

DROSPIRENONE; ETHINYL ESTRADIOL TABLET;ORAL DROSPIRENONE AND ETHINYL ESTRADIOL >D> AB ALLIED 3MG;0.02MG A 203291 001 Jul 18, 2017 Jun CAHN >A> AB HLTHCARE 3MG;0.02MG A 203291 001 Jul 18, 2017 Jun CAHN >D> AB JUBILANT CADISTA 3MG;0.02MG A 209423 001 Dec 22, 2017 Jun DISC >A> @ 3MG;0.02MG A 209423 001 Dec 22, 2017 Jun DISC TABLET;ORAL-28 DROSPIRENONE AND ETHINYL ESTRADIOL >D> AB JUBILANT CADISTA 3MG;0.03MG A 210017 001 Sep 10, 2018 Jun DISC >A> @ 3MG;0.03MG A 210017 001 Sep 10, 2018 Jun DISC

DROXIDOPA CAPSULE;ORAL DROXIDOPA >D> AB BLUEPHARMA 100MG A 214543 001 May 05, 2021 Jun CAHN >D> AB 200MG A 214543 002 May 05, 2021 Jun CAHN >D> AB 300MG A 214543 003 May 05, 2021 Jun CAHN >A> AB TRIS PHARMA INC 100MG A 214543 001 May 05, 2021 Jun CAHN >A> AB 200MG A 214543 002 May 05, 2021 Jun CAHN >A> AB 300MG A 214543 003 May 05, 2021 Jun CAHN

EFAVIRENZ TABLET;ORAL EFAVIRENZ >A> AB STRIDES PHARMA 600MG A 078509 001 Jun 16, 2021 Jun NEWA

EFINACONAZOLE SOLUTION;TOPICAL EFINACONAZOLE >A> AB ACRUX DDS 10% A 211969 001 Jun 21, 2021 Jun NEWA

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR TABLET, TABLET;ORAL TRIKAFTA (COPACKAGED) >D> +! VERTEX PHARMS INC 100MG,75MG,50MG;N/A,150MG,N/A N 212273 001 Oct 21, 2019 Jun CPOT TABLET;ORAL TRIKAFTA (COPACKAGED) >A> + VERTEX PHARMS INC 50MG,37.5MG,25MG; 75MG N 212273 002 Jun 08, 2021 Jun NEWA >A> +! 100MG,75MG,50MG; 150MG N 212273 001 Oct 21, 2019 Jun CPOT

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE >A> AB APOTEX 200MG;300MG A 208740 001 Jun 16, 2021 Jun NEWA >A> AB ZYDUS PHARMS 100MG;150MG A 212689 002 Jul 01, 2021 Jun NEWA >A> AB 133MG;200MG A 212689 003 Jul 01, 2021 Jun NEWA >A> AB 167MG;250MG A 212689 004 Jul 01, 2021 Jun NEWA

EPHEDRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS REZIPRES >A> +! ETON 23.5MG/5ML (4.7MG/ML) N 213536 001 Jun 14, 2021 Jun CAHN >A> + @ 47MG/ML (47MG/ML) N 213536 002 Jun 14, 2021 Jun DISC >A> + @ 47MG/5ML (9.4MG/ML) N 213536 003 Jun 14, 2021 Jun DISC

Page 7 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

EPHEDRINE SULFATE SOLUTION;INTRAVENOUS EPHEDRINE SULFATE >A> AP AUROBINDO PHARMA LTD 50MG/ML (50MG/ML) A 214579 001 Jun 14, 2021 Jun NEWA

ERYTHROMYCIN TABLET;ORAL ERYTHROMYCIN >A> AB ORANGE 250MG A 213628 001 Jun 28, 2021 Jun NEWA >A> AB 500MG A 213628 002 Jun 28, 2021 Jun NEWA

ESLICARBAZEPINE ACETATE TABLET;ORAL >A> ESLICARBAZEPINE ACETATE >A> AB DR REDDYS LABS LTD 200MG A 211238 001 Jun 29, 2021 Jun NFTG >A> AB 400MG A 211238 002 Jun 29, 2021 Jun NFTG >A> AB 600MG A 211238 003 Jun 29, 2021 Jun NFTG >A> AB 800MG A 211238 004 Jun 29, 2021 Jun NFTG

ETHACRYNIC ACID TABLET;ORAL ETHACRYNIC ACID >D> AB ALVOGEN 25MG A 205709 001 Jul 24, 2018 Jun CAHN >A> AB 25MG A 205709 001 Jul 24, 2018 Jun CAHN

ETOMIDATE INJECTABLE;INJECTION ETOMIDATE >D> AP CAPLIN 2MG/ML A 215028 001 Dec 18, 2020 Jun DISC >A> @ 2MG/ML A 215028 001 Dec 18, 2020 Jun DISC

ETRAVIRINE TABLET;ORAL >A> ETRAVIRINE >A> AB AMNEAL 25MG A 214196 001 Jun 14, 2021 Jun NFTG >A> AB 100MG A 214196 002 Jun 14, 2021 Jun NFTG >A> AB 200MG A 214196 003 Jun 14, 2021 Jun NFTG

FELODIPINE TABLET, EXTENDED RELEASE;ORAL FELODIPINE >D> AB JUBILANT GENERICS 2.5MG A 203983 001 Aug 19, 2016 Jun DISC >A> @ 2.5MG A 203983 001 Aug 19, 2016 Jun DISC >D> AB 5MG A 203983 002 Aug 19, 2016 Jun DISC >A> @ 5MG A 203983 002 Aug 19, 2016 Jun DISC >D> AB 10MG A 203983 003 Aug 19, 2016 Jun DISC >A> @ 10MG A 203983 003 Aug 19, 2016 Jun DISC

FENTANYL CITRATE INJECTABLE;INJECTION FENTANYL CITRATE >D> @ FRESENIUS KABI USA EQ 0.05MG BASE/ML A 212086 001 Sep 01, 2020 Jun CMFD >A> AP EQ 0.05MG BASE/ML A 212086 001 Sep 01, 2020 Jun CMFD

FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL FINGOLIMOD HYDROCHLORIDE >D> AB APOTEX EQ 0.5MG BASE A 207993 001 Dec 18, 2020 Jun DISC >A> @ EQ 0.5MG BASE A 207993 001 Dec 18, 2020 Jun DISC

FLECAINIDE ACETATE TABLET;ORAL TAMBOCOR >A> + @ ALVOGEN 50MG N 018830 004 Aug 23, 1988 Jun CAHN >A> + @ 100MG N 018830 001 Oct 31, 1985 Jun CAHN >A> + @ 150MG N 018830 003 Jun 03, 1988 Jun CAHN >A> @ 200MG N 018830 002 Oct 31, 1985 Jun CAHN >D> + @ CNTY LINE PHARMS 50MG N 018830 004 Aug 23, 1988 Jun CAHN >D> + @ 100MG N 018830 001 Oct 31, 1985 Jun CAHN >D> + @ 150MG N 018830 003 Jun 03, 1988 Jun CAHN >D> @ 200MG N 018830 002 Oct 31, 1985 Jun CAHN

Page 8 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FLUOCINONIDE CREAM;TOPICAL LIDEX >A> + @ ALVOGEN 0.05% N 016908 002 Jun 30, 1971 Jun CAHN >D> + @ CNTY LINE PHARMS 0.05% N 016908 002 Jun 30, 1971 Jun CAHN LIDEX-E >A> AB2 + ALVOGEN 0.05% N 016908 003 Sep 19, 1977 Jun CAHN >D> AB2 + CNTY LINE PHARMS 0.05% N 016908 003 Sep 19, 1977 Jun CAHN GEL;TOPICAL FLUOCINONIDE >A> AB + ALVOGEN 0.05% N 017373 001 May 15, 1973 Jun CAHN >D> AB + CNTY LINE PHARMS 0.05% N 017373 001 May 15, 1973 Jun CAHN OINTMENT;TOPICAL LIDEX >A> AB + ALVOGEN 0.05% N 016909 002 Sep 22, 1971 Jun CAHN >D> AB + CNTY LINE PHARMS 0.05% N 016909 002 Sep 22, 1971 Jun CAHN SOLUTION;TOPICAL LIDEX >A> AT + ALVOGEN 0.05% N 018849 001 Apr 06, 1984 Jun CAHN >D> AT + CNTY LINE PHARMS 0.05% N 018849 001 Apr 06, 1984 Jun CAHN

FLUOXETINE HYDROCHLORIDE CAPSULE;ORAL FLUOXETINE HYDROCHLORIDE >D> @ CELLTRION EQ 10MG BASE A 078143 001 Jan 16, 2008 Jun CAHN >D> @ EQ 20MG BASE A 078143 002 Jan 16, 2008 Jun CAHN >D> @ EQ 40MG BASE A 078143 003 Jan 16, 2008 Jun CAHN >A> @ GRANULES EQ 10MG BASE A 078143 001 Jan 16, 2008 Jun CAHN >A> @ EQ 20MG BASE A 078143 002 Jan 16, 2008 Jun CAHN >A> @ EQ 40MG BASE A 078143 003 Jan 16, 2008 Jun CAHN

FLUTAMIDE CAPSULE;ORAL FLUTAMIDE >D> ! PAR PHARM 125MG A 075298 001 Sep 18, 2001 Jun CAHN >A> ! WAYLIS THERAP 125MG A 075298 001 Sep 18, 2001 Jun CAHN

FORMOTEROL FUMARATE SOLUTION;INHALATION >A> FORMOTEROL FUMARATE >A> AN TEVA PHARMS USA INC 0.02MG/2ML A 091141 001 Jun 22, 2021 Jun NFTG

FORMOTEROL FUMARATE; FUROATE AEROSOL, METERED;INHALATION DULERA >D> + MERCK SHARP DOHME 0.005MG/INH;0.05MG/INH N 022518 003 Aug 12, 2019 Jun CAHN >D> +! 0.005MG/INH;0.1MG/INH N 022518 001 Jun 22, 2010 Jun CAHN >D> +! 0.005MG/INH;0.2MG/INH N 022518 002 Jun 22, 2010 Jun CAHN >A> + ORGANON 0.005MG/INH;0.05MG/INH N 022518 003 Aug 12, 2019 Jun CAHN >A> +! 0.005MG/INH;0.1MG/INH N 022518 001 Jun 22, 2010 Jun CAHN >A> +! 0.005MG/INH;0.2MG/INH N 022518 002 Jun 22, 2010 Jun CAHN

FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS FOSAPREPITANT DIMEGLUMINE >A> AP PRAXGEN EQ 150MG BASE/VIAL A 211624 001 Sep 05, 2019 Jun CAHN >D> AP SUNGEN PHARMA EQ 150MG BASE/VIAL A 211624 001 Sep 05, 2019 Jun CAHN

FULVESTRANT INJECTABLE;INTRAMUSCULAR FULVESTRANT >A> AO APOTEX 50MG/ML A 211730 001 Jun 11, 2021 Jun NEWA

FUROSEMIDE INJECTABLE;INJECTION FUROSEMIDE >A> @ HIKMA 10MG/ML N 018267 001 May 19, 1981 Jun CAHN >D> @ WEST-WARD PHARMS INT 10MG/ML N 018267 001 May 19, 1981 Jun CAHN

Page 9 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GABAPENTIN CAPSULE;ORAL GABAPENTIN >D> AB EPIC PHARMA LLC 100MG A 207099 001 Mar 24, 2017 Jun CAHN >D> AB 300MG A 207099 002 Mar 24, 2017 Jun CAHN >D> AB 400MG A 207099 003 Mar 24, 2017 Jun CAHN >A> AB GRAVITI PHARMS 100MG A 207099 001 Mar 24, 2017 Jun CAHN >A> AB 300MG A 207099 002 Mar 24, 2017 Jun CAHN >A> AB 400MG A 207099 003 Mar 24, 2017 Jun CAHN

GATIFLOXACIN SOLUTION/DROPS;OPHTHALMIC GATIFLOXACIN >D> AT MYLAN 0.5% A 206446 001 Jun 08, 2018 Jun DISC >A> @ 0.5% A 206446 001 Jun 08, 2018 Jun DISC

GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION GEMCITABINE HYDROCHLORIDE >A> AP HIKMA INTL PHARMS EQ 200MG BASE/VIAL A 206617 001 Jun 25, 2021 Jun NEWA >A> AP EQ 1GM BASE/VIAL A 206617 002 Jun 25, 2021 Jun NEWA

GENTAMICIN SULFATE INJECTABLE;INJECTION GENTAMICIN SULFATE >A> @ HIKMA EQ 10MG BASE/ML A 062251 002 Jun 05, 1980 Jun CAHN >A> @ EQ 40MG BASE/ML A 062251 001 Jun 05, 1980 Jun CAHN >D> @ WEST-WARD PHARMS INT EQ 10MG BASE/ML A 062251 002 Jun 05, 1980 Jun CAHN >D> @ EQ 40MG BASE/ML A 062251 001 Jun 05, 1980 Jun CAHN

GLECAPREVIR; PIBRENTASVIR >A> PELLETS;ORAL >A> MAVYRET >A> +! ABBVIE INC 50MG;20MG/PACKET N 215110 001 Jun 10, 2021 Jun NEWA

GLYCOPYRROLATE INJECTABLE;INJECTION GLYCOPYRROLATE >A> AP HONG KONG 0.2MG/ML A 212802 001 Jul 06, 2021 Jun NEWA TABLET;ORAL ROBINUL >D> + @ CASPER PHARMA LLC 1MG N 012827 001 Aug 11, 1961 Jun CMFD >A> AA + 1MG N 012827 001 Aug 11, 1961 Jun CMFD ROBINUL FORTE >D> + @ CASPER PHARMA LLC 2MG N 012827 002 Aug 11, 1961 Jun CMFD >A> AA + 2MG N 012827 002 Aug 11, 1961 Jun CMFD

HEPARIN SODIUM INJECTABLE;INJECTION HEPARIN SODIUM >D> AP BE PHARMS 1,000 UNITS/ML A 214804 001 Dec 29, 2020 Jun DISC >A> @ 1,000 UNITS/ML A 214804 001 Dec 29, 2020 Jun DISC >D> AP 10,000 UNITS/ML A 214839 001 Dec 29, 2020 Jun DISC >A> @ 10,000 UNITS/ML A 214839 001 Dec 29, 2020 Jun DISC

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE >D> AB CADISTA PHARMS 12.5MG;50MG A 201845 001 Sep 18, 2012 Jun CAHN >D> AB 12.5MG;100MG A 201845 002 Sep 18, 2012 Jun CAHN >D> AB 25MG;100MG A 201845 003 Sep 18, 2012 Jun CAHN >A> AB JUBILANT CADISTA 12.5MG;50MG A 201845 001 Sep 18, 2012 Jun CAHN >A> AB 12.5MG;100MG A 201845 002 Sep 18, 2012 Jun CAHN >A> AB 25MG;100MG A 201845 003 Sep 18, 2012 Jun CAHN

HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL DUTOPROL >D> + CONCORDIA 12.5MG;EQ 25MG TARTRATE N 021956 001 Aug 28, 2006 Jun DISC >A> + @ 12.5MG;EQ 25MG TARTRATE N 021956 001 Aug 28, 2006 Jun DISC >D> + 12.5MG;EQ 50MG TARTRATE N 021956 002 Aug 28, 2006 Jun DISC

Page 10 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL DUTOPROL >A> + @ 12.5MG;EQ 50MG TARTRATE N 021956 002 Aug 28, 2006 Jun DISC >D> +! 12.5MG;EQ 100MG TARTRATE N 021956 003 Aug 28, 2006 Jun DISC >A> + @ 12.5MG;EQ 100MG TARTRATE N 021956 003 Aug 28, 2006 Jun DISC

IBANDRONATE SODIUM INJECTABLE;INTRAVENOUS IBANDRONATE SODIUM >A> AP NANG KUANG PHARM CO EQ 3MG BASE/3ML A 204329 001 Jun 16, 2021 Jun NEWA

>A> IBREXAFUNGERP CITRATE >A> TABLET;ORAL >A> BREXAFEMME >A> +! SCYNEXIS EQ 150MG BASE N 214900 001 Jun 01, 2021 Jun NEWA

ICOSAPENT ETHYL CAPSULE;ORAL ICOSAPENT ETHYL >A> AB APOTEX 1GM A 209437 001 Jun 30, 2021 Jun NEWA

INDOCYANINE GREEN INJECTABLE;INJECTION INDOCYANINE GREEN >D> AP DIAGNOSTIC GREEN 25MG/VIAL A 040811 001 Nov 21, 2007 Jun CAHN >A> AP RENEW PHARMS 25MG/VIAL A 040811 001 Nov 21, 2007 Jun CAHN

INDOMETHACIN CAPSULE, EXTENDED RELEASE;ORAL INDOMETHACIN >D> AB JUBILANT GENERICS 75MG A 202706 001 Oct 05, 2015 Jun DISC >A> @ 75MG A 202706 001 Oct 05, 2015 Jun DISC

KETOROLAC TROMETHAMINE SOLUTION/DROPS;OPHTHALMIC KETOROLAC TROMETHAMINE >D> AT AUROBINDO PHARMA LTD 0.5% A 205190 001 Dec 03, 2020 Jun DISC >A> @ 0.5% A 205190 001 Dec 03, 2020 Jun DISC

LACTULOSE SOLUTION;ORAL LACTULOSE >D> @ TORRENT 10GM/15ML A 207786 001 Jun 11, 2018 Jun CMFD >A> AA 10GM/15ML A 207786 001 Jun 11, 2018 Jun CMFD SOLUTION;ORAL, RECTAL LACTULOSE >D> @ TORRENT 10GM/15ML A 203762 001 Mar 27, 2015 Jun CMFD >A> AA 10GM/15ML A 203762 001 Mar 27, 2015 Jun CMFD

LAMIVUDINE TABLET;ORAL LAMIVUDINE >A> AB CENTAUR PHARMS PVT 150MG A 203586 001 Nov 21, 2016 Jun CAHN >D> AB PHARMA LIFE 150MG A 203586 001 Nov 21, 2016 Jun CAHN

LAMOTRIGINE TABLET, CHEWABLE;ORAL LAMOTRIGINE >D> AB JUBILANT GENERICS 5MG A 200220 001 Feb 28, 2011 Jun DISC >A> @ 5MG A 200220 001 Feb 28, 2011 Jun DISC >D> AB 25MG A 200220 002 Feb 28, 2011 Jun DISC >A> @ 25MG A 200220 002 Feb 28, 2011 Jun DISC TABLET;ORAL LAMOTRIGINE >D> @ CELLTRION 25MG A 078982 001 Jan 27, 2009 Jun CAHN >D> @ 100MG A 078982 002 Jan 27, 2009 Jun CAHN >D> @ 150MG A 078982 003 Jan 27, 2009 Jun CAHN >D> @ 200MG A 078982 004 Jan 27, 2009 Jun CAHN >A> @ GRANULES 25MG A 078982 001 Jan 27, 2009 Jun CAHN >A> @ 100MG A 078982 002 Jan 27, 2009 Jun CAHN

Page 11 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LAMOTRIGINE TABLET;ORAL LAMOTRIGINE >A> @ 150MG A 078982 003 Jan 27, 2009 Jun CAHN >A> @ 200MG A 078982 004 Jan 27, 2009 Jun CAHN

LANSOPRAZOLE CAPSULE, DELAYED REL PELLETS;ORAL PREVACID >D> AB + TAKEDA PHARMS USA 15MG N 020406 001 May 10, 1995 Jun DISC >A> + @ 15MG N 020406 001 May 10, 1995 Jun DISC

LEFLUNOMIDE TABLET;ORAL LEFLUNOMIDE >A> AB AET PHARMA 10MG A 213497 001 May 10, 2021 Jun CAHN >A> AB 20MG A 213497 002 May 10, 2021 Jun CAHN >D> AB AXUNIO 10MG A 213497 001 May 10, 2021 Jun CAHN >D> AB 20MG A 213497 002 May 10, 2021 Jun CAHN

LEVETIRACETAM INJECTABLE;INTRAVENOUS LEVETIRACETAM >D> AP JUBILANT GENERICS 500MG/5ML (100MG/ML) A 206838 001 Jun 02, 2016 Jun DISC >A> @ 500MG/5ML (100MG/ML) A 206838 001 Jun 02, 2016 Jun DISC TABLET;ORAL LEVETIRACETAM >A> AB SCIEGEN PHARMS INC 750MG A 215069 001 Jun 11, 2021 Jun NEWA >A> AB 1GM A 215069 002 Jun 11, 2021 Jun NEWA

LEVOBUNOLOL HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC >D> BETAGAN >D> AT +! ALLERGAN 0.25% N 019814 001 Jun 28, 1989 Jun DISC >A> + @ 0.25% N 019814 001 Jun 28, 1989 Jun DISC

LEVOFLOXACIN TABLET;ORAL LEVOFLOXACIN >A> AB CADILA 250MG A 077652 001 Sep 07, 2012 Jun CAHN >A> AB 500MG A 077652 002 Sep 07, 2012 Jun CAHN >A> AB 750MG A 077652 003 Sep 07, 2012 Jun CAHN >D> AB JUBILANT GENERICS 250MG A 203613 001 Jun 19, 2015 Jun DISC >A> @ 250MG A 203613 001 Jun 19, 2015 Jun DISC >D> AB 500MG A 203613 002 Jun 19, 2015 Jun DISC >A> @ 500MG A 203613 002 Jun 19, 2015 Jun DISC >D> AB ZYDUS PHARMS USA INC 250MG A 077652 001 Sep 07, 2012 Jun CAHN >D> AB 500MG A 077652 002 Sep 07, 2012 Jun CAHN >D> AB 750MG A 077652 003 Sep 07, 2012 Jun CAHN

LEVORPHANOL TARTRATE TABLET;ORAL LEVORPHANOL TARTRATE >A> AB SUN PHARM INDS INC 2MG A 213906 001 Jun 17, 2021 Jun NEWA

LIDOCAINE PATCH;TOPICAL LIDOCAINE >D> AB NOVEN PHARMS INC 5% A 203265 001 Dec 01, 2020 Jun DISC >A> @ 5% A 203265 001 Dec 01, 2020 Jun DISC

LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM >D> AB CADISTA PHARMS 25MG A 201170 001 Sep 18, 2012 Jun CAHN >D> AB 50MG A 201170 002 Sep 18, 2012 Jun CAHN >D> AB 100MG A 201170 003 Sep 18, 2012 Jun CAHN >A> AB JUBILANT CADISTA 25MG A 201170 001 Sep 18, 2012 Jun CAHN >A> AB 50MG A 201170 002 Sep 18, 2012 Jun CAHN >A> AB 100MG A 201170 003 Sep 18, 2012 Jun CAHN

Page 12 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MAPROTILINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> @ HERITAGE PHARMA 50MG A 072163 001 Jun 01, 1988 Jun CAHN >D> @ WATSON LABS TEVA 50MG A 072163 001 Jun 01, 1988 Jun CAHN

MEMANTINE HYDROCHLORIDE TABLET;ORAL MEMANTINE HYDROCHLORIDE >D> AB JUBILANT GENERICS 5MG A 091585 001 Oct 13, 2015 Jun DISC >A> @ 5MG A 091585 001 Oct 13, 2015 Jun DISC >D> AB 10MG A 091585 002 Oct 13, 2015 Jun DISC >A> @ 10MG A 091585 002 Oct 13, 2015 Jun DISC

METFORMIN HYDROCHLORIDE TABLET;ORAL METFORMIN HYDROCHLORIDE >A> AB CHARTWELL 500MG A 075972 001 Jan 24, 2002 Jun CAHN >A> 625MG A 075972 005 Jan 24, 2002 Jun CAHN >A> 750MG A 075972 004 Jan 24, 2002 Jun CAHN >A> AB 850MG A 075972 002 Jan 24, 2002 Jun CAHN >A> AB 1GM A 075972 003 Jan 24, 2002 Jun CAHN >D> AB CHARTWELL LIFE SCI 500MG A 075972 001 Jan 24, 2002 Jun CAHN >D> 625MG A 075972 005 Jan 24, 2002 Jun CAHN >D> 750MG A 075972 004 Jan 24, 2002 Jun CAHN >D> AB 850MG A 075972 002 Jan 24, 2002 Jun CAHN >D> AB 1GM A 075972 003 Jan 24, 2002 Jun CAHN

METHOCARBAMOL TABLET;ORAL METHOCARBAMOL >D> AA GRANULATION TECH 500MG A 212623 001 Apr 30, 2021 Jun CAHN >D> AA 750MG A 212623 002 Apr 30, 2021 Jun CAHN >A> AA MLV 500MG A 212623 001 Apr 30, 2021 Jun CAHN >A> AA 750MG A 212623 002 Apr 30, 2021 Jun CAHN

METHOTREXATE SODIUM INJECTABLE;INJECTION METHOTREXATE PRESERVATIVE FREE >D> AP FRESENIUS KABI USA EQ 25MG BASE/ML A 040265 001 Feb 26, 1999 Jun DISC >A> @ EQ 25MG BASE/ML A 040265 001 Feb 26, 1999 Jun DISC

METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AB ALVOGEN 10MG A 204772 001 Feb 29, 2016 Jun CAHN >A> AB 20MG A 204772 002 Feb 29, 2016 Jun CAHN >D> AB CNTY LINE PHARMS 10MG A 204772 001 Feb 29, 2016 Jun CAHN >D> AB 20MG A 204772 002 Feb 29, 2016 Jun CAHN TABLET;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> @ ALVOGEN 5MG A 206840 001 Sep 15, 2016 Jun CAHN >A> @ 10MG A 206840 002 Sep 15, 2016 Jun CAHN >A> @ 20MG A 206840 003 Sep 15, 2016 Jun CAHN >D> @ CNTY LINE PHARMS 5MG A 206840 001 Sep 15, 2016 Jun CAHN >D> @ 10MG A 206840 002 Sep 15, 2016 Jun CAHN >D> @ 20MG A 206840 003 Sep 15, 2016 Jun CAHN

MICAFUNGIN SODIUM POWDER;INTRAVENOUS >A> MICAFUNGIN >A> +! PAR STERILE PRODUCTS EQ 50MG BASE/VIAL N 212156 001 Jun 16, 2021 Jun NEWA >A> +! EQ 100MG BASE/VIAL N 212156 002 Jun 16, 2021 Jun NEWA

MINOCYCLINE HYDROCHLORIDE CAPSULE;ORAL DYNACIN >A> AB ALVOGEN EQ 50MG BASE A 063067 003 Aug 14, 1990 Jun CAHN >A> AB EQ 75MG BASE A 063067 002 Sep 15, 1999 Jun CAHN >A> AB EQ 100MG BASE A 063067 001 Jul 31, 1990 Jun CAHN

Page 13 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MINOCYCLINE HYDROCHLORIDE CAPSULE;ORAL DYNACIN >D> AB CNTY LINE PHARMS EQ 50MG BASE A 063067 003 Aug 14, 1990 Jun CAHN >D> AB EQ 75MG BASE A 063067 002 Sep 15, 1999 Jun CAHN >D> AB EQ 100MG BASE A 063067 001 Jul 31, 1990 Jun CAHN

MOMETASONE FUROATE AEROSOL, METERED;INHALATION ASMANEX HFA >D> + MERCK SHARP DOHME 0.05MG/INH N 205641 003 Aug 12, 2019 Jun CAHN >D> + 0.10MG/INH N 205641 001 Apr 25, 2014 Jun CAHN >D> +! 0.20MG/INH N 205641 002 Apr 25, 2014 Jun CAHN >A> + ORGANON 0.05MG/INH N 205641 003 Aug 12, 2019 Jun CAHN >A> + 0.10MG/INH N 205641 001 Apr 25, 2014 Jun CAHN >A> +! 0.20MG/INH N 205641 002 Apr 25, 2014 Jun CAHN POWDER;INHALATION ASMANEX TWISTHALER >D> + MERCK SHARP DOHME 0.11MG/INH N 021067 002 Feb 01, 2008 Jun CAHN >D> +! 0.22MG/INH N 021067 001 Mar 30, 2005 Jun CAHN >A> + ORGANON 0.11MG/INH N 021067 002 Feb 01, 2008 Jun CAHN >A> +! 0.22MG/INH N 021067 001 Mar 30, 2005 Jun CAHN

NIACIN TABLET, EXTENDED RELEASE;ORAL NIACIN >D> AB JUBILANT GENERICS 500MG A 209156 001 May 14, 2018 Jun DISC >A> @ 500MG A 209156 001 May 14, 2018 Jun DISC >D> AB 750MG A 209156 002 May 14, 2018 Jun DISC >A> @ 750MG A 209156 002 May 14, 2018 Jun DISC >D> AB 1GM A 209156 003 May 14, 2018 Jun DISC >A> @ 1GM A 209156 003 May 14, 2018 Jun DISC

NICARDIPINE HYDROCHLORIDE INJECTABLE;INJECTION NICARDIPINE HYDROCHLORIDE >A> AP SUN PHARM 25MG/10ML (2.5MG/ML) N 078405 001 Nov 17, 2009 Jun CMFD >D> @ SUN PHARMA GLOBAL 25MG/10ML (2.5MG/ML) N 078405 001 Nov 17, 2009 Jun CMFD

NIFEDIPINE TABLET, EXTENDED RELEASE;ORAL NIFEDIPINE >D> AB2 ELITE 90MG A 212016 001 Nov 18, 2020 Jun DISC >A> @ 90MG A 212016 001 Nov 18, 2020 Jun DISC

NITROFURANTOIN, MACROCRYSTALLINE CAPSULE;ORAL NITROFURANTOIN >A> AB ALEMBIC PHARMS LTD 25MG A 211935 001 Jun 25, 2021 Jun NEWA >A> AB 50MG A 211935 002 Jun 25, 2021 Jun NEWA >A> AB 100MG A 211935 003 Jun 25, 2021 Jun NEWA

NITROGLYCERIN >D> POWDER;SUBLINGUAL >D> GONITRO >D> +! POHL BOSKAMP 0.4MG/PACKET N 208424 001 Jun 08, 2016 Jun DISC >A> + @ 0.4MG/PACKET N 208424 001 Jun 08, 2016 Jun DISC

NYSTATIN SUSPENSION;ORAL NYSTATIN >A> AA NIVAGEN PHARMS INC 100,000 UNITS/ML A 062832 001 Dec 27, 1991 Jun CAHN >D> AA SOCORRO 100,000 UNITS/ML A 062832 001 Dec 27, 1991 Jun CAHN

OFLOXACIN SOLUTION/DROPS;OPHTHALMIC OFLOXACIN >D> @ ALVOGEN 0.3% A 076830 001 Aug 31, 2004 Jun CAHN >A> @ 0.3% A 076830 001 Aug 31, 2004 Jun CAHN

Page 14 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

OFLOXACIN SOLUTION/DROPS;OTIC OFLOXACIN >D> @ ALVOGEN 0.3% A 090395 001 Aug 11, 2009 Jun CAHN >A> @ 0.3% A 090395 001 Aug 11, 2009 Jun CAHN

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC HYDROCHLORIDE >D> AT AKORN EQ 0.1% BASE A 204532 001 Jan 10, 2017 Jun CMKT >D> EQ 0.2% BASE A 204723 001 Dec 05, 2017 Jun CMKT

ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE >D> AP HOSPIRA EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Jun DISC >A> @ EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Jun DISC

OXCARBAZEPINE SUSPENSION;ORAL OXCARBAZEPINE >A> AB GLASSHOUSE PHARMS 300MG/5ML A 212428 001 Jun 21, 2021 Jun NEWA

OXYBUTYNIN CHLORIDE TABLET;ORAL CHLORIDE >D> AB STRIDES PHARMA 5MG A 208165 001 Dec 17, 2020 Jun DISC >A> @ 5MG A 208165 001 Dec 17, 2020 Jun DISC

PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR >A> PALIPERIDONE PALMITATE >A> AP TEVA PHARMS USA 39MG/0.25ML (39MG/0.25ML) A 211149 001 Jul 06, 2021 Jun NFTG >A> AP 78MG/0.5ML (78MG/0.5ML) A 211149 002 Jul 06, 2021 Jun NFTG >A> AP 117MG/0.75ML (117MG/0.75ML) A 211149 003 Jul 06, 2021 Jun NFTG >A> AP 156MG/ML (156MG/ML) A 211149 004 Jul 06, 2021 Jun NFTG >A> AP 234MG/1.5ML (156MG/ML) A 211149 005 Jul 06, 2021 Jun NFTG

PALONOSETRON HYDROCHLORIDE INJECTABLE;INTRAVENOUS PALONOSETRON HYDROCHLORIDE >A> EMCURE PHARMS LTD EQ 0.075MG BASE/1.5ML (EQ A 202951 001 Jun 29, 2021 Jun NEWA 0.05MG BASE/ML) >A> AP EQ 0.25MG BASE/5ML (EQ 0.05MG A 202951 002 Jun 29, 2021 Jun NEWA BASE/ML)

PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE;ORAL PANTOPRAZOLE SODIUM >D> AB JUBILANT GENERICS EQ 20MG BASE A 090901 001 Aug 30, 2011 Jun DISC >A> @ EQ 20MG BASE A 090901 001 Aug 30, 2011 Jun DISC >D> AB EQ 40MG BASE A 090901 002 Aug 30, 2011 Jun DISC >A> @ EQ 40MG BASE A 090901 002 Aug 30, 2011 Jun DISC

PATIROMER SORBITEX CALCIUM POWDER;ORAL VELTASSA >D> + RELYPSA INC EQ 8.4GM BASE/PACKET N 205739 001 Oct 21, 2015 Jun CAHN >D> + EQ 16.8GM BASE/PACKET N 205739 002 Oct 21, 2015 Jun CAHN >D> +! EQ 25.2GM BASE/PACKET N 205739 003 Oct 21, 2015 Jun CAHN >A> + VIFOR PHARMA EQ 8.4GM BASE/PACKET N 205739 001 Oct 21, 2015 Jun CAHN >A> + EQ 16.8GM BASE/PACKET N 205739 002 Oct 21, 2015 Jun CAHN >A> +! EQ 25.2GM BASE/PACKET N 205739 003 Oct 21, 2015 Jun CAHN

PERAMPANEL TABLET;ORAL FYCOMPA >D> AB + EISAI INC 2MG N 202834 001 Oct 22, 2012 Jun CTEC >A> + 2MG N 202834 001 Oct 22, 2012 Jun CTEC >D> AB + 4MG N 202834 002 Oct 22, 2012 Jun CTEC >A> + 4MG N 202834 002 Oct 22, 2012 Jun CTEC

Page 15 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PERAMPANEL TABLET;ORAL FYCOMPA >D> AB + 6MG N 202834 003 Oct 22, 2012 Jun CTEC >A> + 6MG N 202834 003 Oct 22, 2012 Jun CTEC >D> AB + 8MG N 202834 004 Oct 22, 2012 Jun CTEC >A> + 8MG N 202834 004 Oct 22, 2012 Jun CTEC >D> AB + 10MG N 202834 005 Oct 22, 2012 Jun CTEC >A> + 10MG N 202834 005 Oct 22, 2012 Jun CTEC >D> AB +! 12MG N 202834 006 Oct 22, 2012 Jun CTEC >A> +! 12MG N 202834 006 Oct 22, 2012 Jun CTEC

PRAMIPEXOLE DIHYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >A> AB XIAMEN LP PHARM CO 0.375MG A 212797 001 Jun 11, 2021 Jun NEWA >A> AB 0.75MG A 212797 002 Jun 11, 2021 Jun NEWA

PRAVASTATIN SODIUM TABLET;ORAL PRAVACHOL >D> AB + BRISTOL MYERS SQUIBB 20MG N 019898 003 Oct 31, 1991 Jun DISC >A> + @ 20MG N 019898 003 Oct 31, 1991 Jun DISC >D> AB + 40MG N 019898 004 Mar 22, 1993 Jun DISC >A> + @ 40MG N 019898 004 Mar 22, 1993 Jun DISC >D> AB +! 80MG N 019898 008 Dec 18, 2001 Jun DISC >A> + @ 80MG N 019898 008 Dec 18, 2001 Jun DISC PRAVASTATIN SODIUM >D> AB TEVA PHARMS 80MG A 077793 001 Jan 15, 2008 Jun CHRS >A> AB ! 80MG A 077793 001 Jan 15, 2008 Jun CHRS

PREDNISONE TABLET;ORAL PREDNISONE >A> AB NOVITIUM PHARMA 1MG A 215246 001 Jul 06, 2021 Jun NEWA

PREGABALIN CAPSULE;ORAL PREGABALIN >A> AB APOTEX 25MG A 211685 001 Jul 07, 2021 Jun NEWA >A> AB 50MG A 211685 002 Jul 07, 2021 Jun NEWA >A> AB 75MG A 211685 003 Jul 07, 2021 Jun NEWA >A> AB 100MG A 211685 004 Jul 07, 2021 Jun NEWA >A> AB 150MG A 211685 005 Jul 07, 2021 Jun NEWA >A> AB 200MG A 211685 006 Jul 07, 2021 Jun NEWA >A> AB 225MG A 211685 007 Jul 07, 2021 Jun NEWA >A> AB 300MG A 211685 008 Jul 07, 2021 Jun NEWA TABLET, EXTENDED RELEASE;ORAL PREGABALIN >A> AB ALVOGEN 82.5MG A 211687 001 Jul 06, 2021 Jun NEWA >A> AB 165MG A 211687 002 Jul 06, 2021 Jun NEWA >A> AB 330MG A 211687 003 Jul 06, 2021 Jun NEWA >A> AB MYLAN 330MG A 211431 001 Jul 02, 2021 Jun NEWA

QUETIAPINE FUMARATE TABLET, EXTENDED RELEASE;ORAL FUMARATE >D> AB ANCHEN PHARMS EQ 150MG BASE A 090757 001 Dec 01, 2017 Jun DISC >A> @ EQ 150MG BASE A 090757 001 Dec 01, 2017 Jun DISC >D> AB EQ 200MG BASE A 090757 002 Dec 01, 2017 Jun DISC >A> @ EQ 200MG BASE A 090757 002 Dec 01, 2017 Jun DISC >D> AB EQ 300MG BASE A 090757 003 Dec 01, 2017 Jun DISC >A> @ EQ 300MG BASE A 090757 003 Dec 01, 2017 Jun DISC >D> AB EQ 400MG BASE A 090757 004 Dec 01, 2017 Jun DISC >A> @ EQ 400MG BASE A 090757 004 Dec 01, 2017 Jun DISC TABLET;ORAL QUETIAPINE FUMARATE >D> AB JUBILANT GENERICS EQ 25MG BASE A 203150 001 Nov 26, 2013 Jun DISC >A> @ EQ 25MG BASE A 203150 001 Nov 26, 2013 Jun DISC

Page 16 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RANITIDINE HYDROCHLORIDE CAPSULE;ORAL RANITIDINE HYDROCHLORIDE >D> AB AUROBINDO PHARMA LTD EQ 150MG BASE A 211058 001 Jul 16, 2018 Jun DISC >A> @ EQ 150MG BASE A 211058 001 Jul 16, 2018 Jun DISC >D> AB EQ 300MG BASE A 211058 002 Jul 16, 2018 Jun DISC >A> @ EQ 300MG BASE A 211058 002 Jul 16, 2018 Jun DISC SYRUP;ORAL RANITIDINE HYDROCHLORIDE >D> AA AUROBINDO PHARMA LTD EQ 15MG BASE/ML A 090623 001 Jul 28, 2010 Jun DISC >A> @ EQ 15MG BASE/ML A 090623 001 Jul 28, 2010 Jun DISC

RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING;ORAL RIZATRIPTAN BENZOATE >D> AB JUBILANT GENERICS EQ 5MG BASE A 203334 001 Oct 16, 2015 Jun DISC >A> @ EQ 5MG BASE A 203334 001 Oct 16, 2015 Jun DISC >D> AB EQ 10MG BASE A 203334 002 Oct 16, 2015 Jun DISC >A> @ EQ 10MG BASE A 203334 002 Oct 16, 2015 Jun DISC

ROPINIROLE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL REQUIP XL >D> AB +! GLAXOSMITHKLINE LLC EQ 2MG BASE N 022008 001 Jun 13, 2008 Jun DISC >A> + @ EQ 2MG BASE N 022008 001 Jun 13, 2008 Jun DISC >D> AB + EQ 6MG BASE N 022008 006 Apr 10, 2009 Jun DISC >A> + @ EQ 6MG BASE N 022008 006 Apr 10, 2009 Jun DISC >D> AB + EQ 12MG BASE N 022008 005 Oct 31, 2008 Jun DISC >A> + @ EQ 12MG BASE N 022008 005 Oct 31, 2008 Jun DISC ROPINIROLE HYDROCHLORIDE >D> AB DR REDDYS LABS LTD EQ 2MG BASE A 201576 001 Jun 06, 2012 Jun CHRS >A> AB ! EQ 2MG BASE A 201576 001 Jun 06, 2012 Jun CHRS

SAPROPTERIN DIHYDROCHLORIDE TABLET;ORAL SAPROPTERIN DIHYDROCHLORIDE >A> AB DR REDDYS 100MG A 207685 001 Jun 15, 2021 Jun NEWA

SEMAGLUTIDE >A> SOLUTION;SUBCUTANEOUS >A> WEGOVY >A> +! NOVO 0.25MG/0.5ML (0.25MG/0.5ML) N 215256 001 Jun 04, 2021 Jun NEWA >A> +! 0.5MG/0.5ML (0.5MG/0.5ML) N 215256 002 Jun 04, 2021 Jun NEWA >A> +! 1MG/0.5ML (1MG/0.5ML) N 215256 003 Jun 04, 2021 Jun NEWA >A> +! 1.7MG/0.75ML (1.7MG/0.75ML) N 215256 004 Jun 04, 2021 Jun NEWA >A> +! 2.4MG/0.75ML (2.4MG/0.75ML) N 215256 005 Jun 04, 2021 Jun NEWA

SEVELAMER HYDROCHLORIDE TABLET;ORAL SEVELAMER HYDROCHLORIDE >A> AB LUPIN LTD 400MG A 213145 001 Jun 16, 2021 Jun NEWA >A> AB 800MG A 213145 002 Jun 16, 2021 Jun NEWA

SILDENAFIL CITRATE TABLET;ORAL SILDENAFIL CITRATE >A> AB UMEDICA LABS PVT LTD EQ 25MG BASE A 209302 003 Jun 15, 2021 Jun NEWA

SIMVASTATIN TABLET;ORAL SIMVASTATIN >D> AB LUPIN 80MG A 078103 004 May 11, 2007 Jun CHRS >A> AB ! 80MG A 078103 004 May 11, 2007 Jun CHRS ZOCOR >D> AB +! ORGANON 80MG N 019766 005 Jul 10, 1998 Jun DISC >A> + @ 80MG N 019766 005 Jul 10, 1998 Jun DISC

Page 17 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

SODIUM BENZOATE; SODIUM PHENYLACETATE SOLUTION;INTRAVENOUS SODIUM PHENYLACETATE AND SODIUM BENZOATE >A> +! MAIA PHARMS INC 10%;10% (2GM/20ML;2GM/20ML) N 215025 001 Jun 10, 2021 Jun NEWA

SODIUM CHLORIDE INJECTABLE;INJECTION SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER >D> AP JUBILANT CADISTA 9MG/ML A 203352 001 May 18, 2016 Jun DISC >A> @ 9MG/ML A 203352 001 May 18, 2016 Jun DISC

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE >D> AP AUROBINDO PHARMA LTD 25MG/ML A 211934 001 Dec 10, 2020 Jun DISC >A> @ 25MG/ML A 211934 001 Dec 10, 2020 Jun DISC

SOFOSBUVIR; VELPATASVIR >A> PELLETS;ORAL >A> EPCLUSA >A> + GILEAD SCIENCES INC 150MG;37.5MG/PACKET N 214187 001 Jun 10, 2021 Jun NEWA >A> +! 200MG;50MG/PACKET N 214187 002 Jun 10, 2021 Jun NEWA

SOLIFENACIN SUCCINATE TABLET;ORAL SUCCINATE >D> AB AJANTA PHARMA LTD 5MG A 205483 001 May 20, 2019 Jun DISC >A> @ 5MG A 205483 001 May 20, 2019 Jun DISC >D> AB 10MG A 205483 002 May 20, 2019 Jun DISC >A> @ 10MG A 205483 002 May 20, 2019 Jun DISC

SULFASALAZINE TABLET;ORAL SULFASALAZINE >D> @ CHARTWELL 500MG A 080197 001 Nov 12, 1973 Jun CMFD >A> AB 500MG A 080197 001 Nov 12, 1973 Jun CMFD

TAMSULOSIN HYDROCHLORIDE CAPSULE;ORAL TAMSULOSIN HYDROCHLORIDE >D> AB ANCHEN PHARMS 0.4MG A 202010 001 Jan 04, 2013 Jun DISC >A> @ 0.4MG A 202010 001 Jan 04, 2013 Jun DISC

TESTOSTERONE SOLUTION, METERED;TRANSDERMAL TESTOSTERONE >A> AT ALEOR DERMACEUTICALS 30MG/1.5ML ACTUATION A 212882 001 Jun 14, 2021 Jun NEWA

THALLOUS CHLORIDE TL-201 INJECTABLE;INJECTION THALLOUS CHLORIDE TL 201 >D> AP +! GE HEALTHCARE 1mCi/ML N 018110 002 Feb 27, 1996 Jun DISC >A> + @ 1mCi/ML N 018110 002 Feb 27, 1996 Jun DISC

TIZANIDINE HYDROCHLORIDE CAPSULE;ORAL TIZANIDINE HYDROCHLORIDE >D> AB PAR PHARM INC EQ 2MG BASE A 207199 001 Mar 14, 2017 Jun DISC >A> @ EQ 2MG BASE A 207199 001 Mar 14, 2017 Jun DISC >D> AB EQ 4MG BASE A 207199 002 Mar 14, 2017 Jun DISC >A> @ EQ 4MG BASE A 207199 002 Mar 14, 2017 Jun DISC >D> AB EQ 6MG BASE A 207199 003 Mar 14, 2017 Jun DISC >A> @ EQ 6MG BASE A 207199 003 Mar 14, 2017 Jun DISC

TORSEMIDE TABLET;ORAL >A> SOAANZ >A> + SARFE PHARMS 20MG N 213218 001 Jun 14, 2021 Jun NEWA >A> +! 60MG N 213218 002 Jun 14, 2021 Jun NEWA

Page 18 of 21 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TRANEXAMIC ACID INJECTABLE;INJECTION TRANEXAMIC ACID >D> @ CAPLIN 100MG/ML A 212360 001 Jul 17, 2019 Jun CMFD >A> AP 100MG/ML A 212360 001 Jul 17, 2019 Jun CMFD TABLET;ORAL TRANEXAMIC ACID >D> @ ANI PHARMS 650MG A 203256 001 Jul 25, 2016 Jun CMFD >A> AB 650MG A 203256 001 Jul 25, 2016 Jun CMFD

TRAZODONE HYDROCHLORIDE TABLET;ORAL TRAZODONE HYDROCHLORIDE >D> AB ALVOGEN 50MG A 071636 001 Apr 18, 1988 Jun DISC >A> @ 50MG A 071636 001 Apr 18, 1988 Jun DISC >D> AB 100MG A 071514 001 Apr 18, 1988 Jun DISC >A> @ 100MG A 071514 001 Apr 18, 1988 Jun DISC

TREPROSTINIL >D> SOLUTION;INTRAVENOUS, SUBCUTANEOUS >D> REMODULIN >D> UNITED THERAP 20MG/20ML (1MG/ML) N 208276 001 Jul 30, 2018 Jun DISC >A> @ 20MG/20ML (1MG/ML) N 208276 001 Jul 30, 2018 Jun DISC >D> 50MG/20ML (2.5MG/ML) N 208276 002 Jul 30, 2018 Jun DISC >A> @ 50MG/20ML (2.5MG/ML) N 208276 002 Jul 30, 2018 Jun DISC >D> 100MG/20ML (5MG/ML) N 208276 003 Jul 30, 2018 Jun DISC >A> @ 100MG/20ML (5MG/ML) N 208276 003 Jul 30, 2018 Jun DISC >D> 200MG/20ML (10MG/ML) N 208276 004 Jul 30, 2018 Jun DISC >A> @ 200MG/20ML (10MG/ML) N 208276 004 Jul 30, 2018 Jun DISC

TRIENTINE HYDROCHLORIDE CAPSULE;ORAL CLOVIQUE >D> AB CHARTWELL RX 250MG A 209731 001 Oct 21, 2019 Jun DISC >A> @ 250MG A 209731 001 Oct 21, 2019 Jun DISC TRIENTINE HYDROCHLORIDE >D> AB CHARTWELL RX 250MG A 209415 001 Sep 16, 2019 Jun DISC >A> @ 250MG A 209415 001 Sep 16, 2019 Jun DISC

VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL VENLAFAXINE HYDROCHLORIDE >A> AB ALKEM LABS LTD EQ 37.5MG BASE A 214127 001 Jun 10, 2021 Jun NEWA >A> AB EQ 75MG BASE A 214127 002 Jun 10, 2021 Jun NEWA >A> AB EQ 150MG BASE A 214127 003 Jun 10, 2021 Jun NEWA >A> AB EQ 225MG BASE A 214127 004 Jun 10, 2021 Jun NEWA >A> AB APPCO EQ 150MG BASE A 214609 001 Jun 30, 2021 Jun NEWA >A> AB EQ 225MG BASE A 214609 002 Jun 30, 2021 Jun NEWA

ZONISAMIDE CAPSULE;ORAL ZONISAMIDE >D> AB CELLTRION 25MG A 077636 003 Jul 27, 2006 Jun CAHN >D> AB 50MG A 077636 002 Jul 27, 2006 Jun CAHN >D> AB 100MG A 077636 001 Dec 22, 2005 Jun CAHN >A> AB GRANULES 25MG A 077636 003 Jul 27, 2006 Jun CAHN >A> AB 50MG A 077636 002 Jul 27, 2006 Jun CAHN >A> AB 100MG A 077636 001 Dec 22, 2005 Jun CAHN

Page 19 of 21 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

ASPIRIN CAPSULE;ORAL VAZALORE >A> + PLX PHARMA 81MG N 203697 002 Feb 26, 2021 Jun NEWA

AZELASTINE HYDROCHLORIDE SPRAY, METERED;NASAL >A> ASTEPRO ALLERGY >A> +! BAYER HLTHCARE 0.2055MG/SPRAY N 213872 001 Jun 17, 2021 Jun NEWA >A> CHILDREN'S ASTEPRO ALLERGY >A> +! BAYER HLTHCARE 0.2055MG/SPRAY N 213872 002 Jun 17, 2021 Jun NEWA

DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE >A> SUN PHARM 30MG;600MG A 214781 001 Jul 01, 2021 Jun NEWA >A> 60MG;1.2GM A 214781 002 Jul 01, 2021 Jun NEWA

DICLOFENAC SODIUM GEL;TOPICAL DICLOFENAC SODIUM >A> PERRIGO 1% A 211253 001 May 16, 2019 Jun CAHN >D> PERRIGO UK FINCO 1% A 211253 001 May 16, 2019 Jun CAHN

FEXOFENADINE HYDROCHLORIDE SUSPENSION;ORAL CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY >D> @ TARO 30MG/5ML A 208123 001 Nov 09, 2017 Jun CMFD >A> 30MG/5ML A 208123 001 Nov 09, 2017 Jun CMFD CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES >D> @ TARO 30MG/5ML A 208123 002 Nov 09, 2017 Jun CMFD >A> 30MG/5ML A 208123 002 Nov 09, 2017 Jun CMFD TABLET;ORAL FEXOFENADINE HYDROCHLORIDE >D> @ L PERRIGO CO 60MG A 212971 001 Feb 24, 2020 Jun CMFD >A> 60MG A 212971 001 Feb 24, 2020 Jun CMFD >D> @ 180MG A 212971 002 Feb 24, 2020 Jun CMFD >A> 180MG A 212971 002 Feb 24, 2020 Jun CMFD

LOPERAMIDE HYDROCHLORIDE; SIMETHICONE TABLET;ORAL LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE >A> HETERO LABS LTD V 2MG;125MG A 211438 001 Jun 17, 2021 Jun NEWA

LORATADINE TABLET, ORALLY DISINTEGRATING;ORAL LORATADINE >D> @ TENSHI 5MG A 212795 001 Sep 18, 2020 Jun CMFD >A> 5MG A 212795 001 Sep 18, 2020 Jun CMFD >D> @ 10MG A 213294 001 Oct 30, 2020 Jun CMFD >A> 10MG A 213294 001 Oct 30, 2020 Jun CMFD

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE >A> AKORN EQ 0.1% BASE A 204532 001 Jan 10, 2017 Jun CMKT >A> EQ 0.2% BASE A 204723 001 Dec 05, 2017 Jun CMKT >A> @ BAUSCH EQ 0.1% BASE A 206046 001 Jul 26, 2017 Jun CAHN >D> @ CIPLA EQ 0.1% BASE A 206046 001 Jul 26, 2017 Jun CAHN >D> MICRO LABS LTD INDIA EQ 0.2% BASE A 204620 001 Jun 16, 2020 Jun CAHN >A> MYLAN EQ 0.2% BASE A 204620 001 Jun 16, 2020 Jun CAHN

Page 20 of 21 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

RANITIDINE HYDROCHLORIDE TABLET;ORAL RANITIDINE HYDROCHLORIDE >D> AUROBINDO PHARMA LTD EQ 75MG BASE A 207579 001 Nov 13, 2017 Jun DISC >A> @ EQ 75MG BASE A 207579 001 Nov 13, 2017 Jun DISC >D> EQ 150MG BASE A 207578 001 Nov 13, 2017 Jun DISC >A> @ EQ 150MG BASE A 207578 001 Nov 13, 2017 Jun DISC

CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMKT Change. RX to OTC marketing status switch. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 21 of 21